Jan Christop L. Merene

Array ( [id] => 10831032 [patent_doc_number] => 08859197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Sperm-specific cation channel, CATSPER3, and uses therefor' [patent_app_type] => utility [patent_app_number] => 13/361426 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 20077 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995453 [patent_doc_number] => 09040046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Sodium pump antibody agonists and methods of treating heart disease using the same' [patent_app_type] => utility [patent_app_number] => 13/359723 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 17854 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281557 [patent_doc_number] => 20140031525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'MUTANT G-PROTEIN COUPLED RECEPTOR PROTEINS AND METHODS FOR PRODUCING THEM' [patent_app_type] => utility [patent_app_number] => 13/980497 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12858 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8198149 [patent_doc_number] => 20120122119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'METHODS OF IDENTIFYING COMPOUNDS THAT BIND TO A TOLL-LIKE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/355039 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5700 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122119.pdf [firstpage_image] =>[orig_patent_app_number] => 13355039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10187629 [patent_doc_number] => 09217040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Therapeutic antibodies against ROR-1 protein and methods for use of same' [patent_app_type] => utility [patent_app_number] => 13/997934 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 7059 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13997934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477148 [patent_doc_number] => 20120276554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'ISOLATION AND USE OF RYANODINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/347091 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 21822 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13347091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289839 [patent_doc_number] => 20120178163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 13/345489 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29692 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9331048 [patent_doc_number] => 20140057830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'ALPHABODIES SPECIFICALLY BINDING TO CYTOKINES OR GROWTH FACTORS AND/OR CYTOKINE OR GROWTH FACTOR RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/994107 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 41319 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10595504 [patent_doc_number] => 09316588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Bioassay method for detecting physiologically active substance' [patent_app_type] => utility [patent_app_number] => 13/997489 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 17829 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13997489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11800700 [patent_doc_number] => 09541565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Biomarkers for sensitive detection of statin-induced muscle toxicity' [patent_app_type] => utility [patent_app_number] => 13/332773 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241024 [patent_doc_number] => 20120149765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'SGK1 AS DIAGNOSTIC AND THERAPEUTIC TARGET' [patent_app_type] => utility [patent_app_number] => 13/315850 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4198 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277345 [patent_doc_number] => 20120171219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'USE OF PKC-ZETA AS A BREAST CANCER TUMORIGENIC BIOMARKER AS WELL AS A TARGET FOR TREATMENT OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/309018 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6835 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9054018 [patent_doc_number] => 20130251732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'TARGETING OF CYP1B1 IN THE TREATMENT OF HEAD AND NECK CANCER AND LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 13/990650 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14558 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11888034 [patent_doc_number] => 09758586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Chimeric rabbit/human ROR1 antibodies' [patent_app_type] => utility [patent_app_number] => 13/990977 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14317 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300965 [patent_doc_number] => 20120183523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Methods and Compounds for Promoting Vessel Regression' [patent_app_type] => utility [patent_app_number] => 13/295834 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17272 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766159 [patent_doc_number] => 20120034219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'USES OF IL-23 AGONISTS AND ANTAGONISTS; RELATED REAGENTS' [patent_app_type] => utility [patent_app_number] => 13/270077 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034219.pdf [firstpage_image] =>[orig_patent_app_number] => 13270077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8153895 [patent_doc_number] => 20120097565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies' [patent_app_type] => utility [patent_app_number] => 13/253103 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15103 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20120097565.pdf [firstpage_image] =>[orig_patent_app_number] => 13253103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951199 [patent_doc_number] => 20130196980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'DIAGNOSTIC AGENT, DIAGNOSTIC METHOD AND THERAPEUTIC AGENT FOR FIBROMYALGIA' [patent_app_type] => utility [patent_app_number] => 13/877848 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3197 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791765 [patent_doc_number] => 20120053321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/252723 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48548 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053321.pdf [firstpage_image] =>[orig_patent_app_number] => 13252723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094803 [patent_doc_number] => 20120083001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'METHOD FOR TRANSPORTING POTASSIUM IONS FROM FRONT SIDE TO BACK SIDE OF LIPID BILAYER MEMBRANE' [patent_app_type] => utility [patent_app_number] => 13/248880 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 9531 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083001.pdf [firstpage_image] =>[orig_patent_app_number] => 13248880 [rel_patent_id] =>[rel_patent_doc_number] =>)